Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Crescent Biopharma, Inc. CBIO

Full chart Compare
Set alert

Price alert · CBIO

All alert types
13.06 USD +0.15 (+1.16%)

At closeNov 3, 2026, 4:01 PM EST

13.06 0.00 0.00%

After hours · Nov 3, 4:01 PM ET

12.91 Day range 13.64
8.94 52-week range 26.98
YTD
+10.12%
1 year
+5.75%

Financial health

Altman Z-Score

11.46 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 4
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -0.8×
FY 2016: -4.1×FY 2017: -14.8×FY 2018: -8.1×FY 2019: -4.0×FY 2020: -3.4×FY 2021: -1.2×FY 2022: -3.4×FY 2023: -4.1×FY 2024: -0.4×FY 2025: -0.8×
FY 2016 5y median -1.2× FY 2025
P/S 11.4×
FY 2016: 7009×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 16.9×FY 2021: 63.9×FY 2022: 2122×FY 2023: 14949×FY 2024: 0.0×FY 2025: 11.4×
FY 2016 5y median 63.9× FY 2025
P/B 0.6×
FY 2016: 3.7×FY 2017: 4.1×FY 2018: 1.9×FY 2019: 1.5×FY 2020: 1.3×FY 2021: 0.9×FY 2022: 3.7×FY 2023: 3.9×FY 2024: -1.2×FY 2025: 0.6×
FY 2016 5y median 0.9× FY 2025
P/FCF -0.9×
FY 2016: -4.3×FY 2017: -16.4×FY 2018: -8.9×FY 2019: -4.4×FY 2020: -4.4×FY 2021: -1.3×FY 2022: -3.4×FY 2023: -4.3×FY 2024: -0.6×FY 2025: -0.9×
FY 2016 5y median -1.3× FY 2025
EV/EBITDA 0.6×
FY 2016: -2.8×FY 2017: -11.0×FY 2018: -3.5×FY 2019: -1.3×FY 2020: -0.7×FY 2021: 0.2×FY 2022: -2.4×FY 2023: -2.8×FY 2024: -0.5×FY 2025: 0.6×
FY 2016 5y median -0.5× FY 2025
EV/Sales -8.1×
FY 2016: 4844×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 3.7×FY 2021: -12.3×FY 2022: 1496×FY 2023: 10850×FY 2024: 0.0×FY 2025: -8.1×
FY 2016 5y median 0.0× FY 2025
FCF Yield -117.0%
FY 2016: -23.5%FY 2017: -6.1%FY 2018: -11.2%FY 2019: -22.8%FY 2020: -22.9%FY 2021: -77.6%FY 2022: -29.2%FY 2023: -23.3%FY 2024: -162.8%FY 2025: -117.0%
FY 2016 5y median -77.6% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 0.0%FY 2025: 100.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -1407.5%
FY 2016: -172505.3%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -506.8%FY 2021: -5470.7%FY 2022: -63204.4%FY 2023: -392752.9%FY 2024: 0.0%FY 2025: -1407.5%
FY 2016 5y median -5470.7% FY 2025
Net Margin -1419.6%
FY 2016: -171945.1%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -502.1%FY 2021: -5469.0%FY 2022: -62251.7%FY 2023: -368994.2%FY 2024: 0.0%FY 2025: -1419.6%
FY 2016 5y median -5469.0% FY 2025
ROE -75.8%
FY 2016: -90.1%FY 2017: -27.8%FY 2018: -23.5%FY 2019: -35.1%FY 2020: -39.8%FY 2021: -77.7%FY 2022: -108.8%FY 2023: -96.1%FY 2024: 313.5%FY 2025: -75.8%
FY 2016 5y median -77.7% FY 2025
ROIC -74.6%
FY 2016: -88.5%FY 2017: -28.2%FY 2018: -25.0%FY 2019: -36.4%FY 2020: -39.2%FY 2021: -76.0%FY 2022: -108.1%FY 2023: -100.1%FY 2024: -191.9%FY 2025: -74.6%
FY 2016 5y median -100.1% FY 2025
ROA -64.1%
FY 2016: -75.0%FY 2017: -25.9%FY 2018: -22.5%FY 2019: -32.2%FY 2020: -35.7%FY 2021: -67.2%FY 2022: -90.1%FY 2023: -81.4%FY 2024: -136.2%FY 2025: -64.1%
FY 2016 5y median -81.4% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: -99.9%FY 2017: -100.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -88.6%FY 2022: -93.5%FY 2023: -86.7%FY 2024: -100.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -205.9%
FY 2016: -149.6%FY 2017: -6.3%FY 2018: -51.8%FY 2019: -19.2%FY 2020: 16.1%FY 2021: -23.2%FY 2022: 25.3%FY 2023: 17.1%FY 2024: -27.0%FY 2025: -205.9%
FY 2016 FY 2025
EPS (diluted) 76.6%
FY 2016: -122.8%FY 2017: 24.3%FY 2018: -3.9%FY 2019: -13.8%FY 2020: 16.6%FY 2021: -10.5%FY 2022: 27.9%FY 2023: 34.5%FY 2024: -8.5%FY 2025: 76.6%
FY 2016 FY 2025
Free Cash Flow -364.4%
FY 2016: -257.6%FY 2017: 1.2%FY 2018: -44.6%FY 2019: -20.0%FY 2020: 24.6%FY 2021: -46.3%FY 2022: 19.1%FY 2023: 25.0%FY 2024: 10.9%FY 2025: -364.4%
FY 2016 FY 2025

Financial Health

Current Ratio 6.6×
FY 2016: 6.4×FY 2017: 15.6×FY 2018: 24.2×FY 2019: 14.8×FY 2020: 11.1×FY 2021: 7.7×FY 2022: 5.7×FY 2023: 6.4×FY 2024: 3.6×FY 2025: 6.6×
FY 2016 5y median 6.4× FY 2025
Quick Ratio 6.6×
FY 2016: 6.4×FY 2017: 15.6×FY 2018: 24.2×FY 2019: 14.8×FY 2020: 11.1×FY 2021: 7.7×FY 2022: 5.7×FY 2023: 6.4×FY 2024: 3.6×FY 2025: 6.6×
FY 2016 5y median 6.4× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -2.4×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 1.4×
FY 2016: 1.3×FY 2017: 3.7×FY 2018: 4.1×FY 2019: 2.7×FY 2020: 2.6×FY 2021: 1.4×FY 2022: 1.0×FY 2023: 1.0×FY 2024: -0.1×FY 2025: 1.4×
FY 2016 5y median 1.0× FY 2025
Interest Coverage -69.9×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -58.6×FY 2025: -69.9×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 47.2%FY 2023: 10.2%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -160.9%FY 2023: -41.2%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31